Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1241-1250 of 1,298) with videos related to

Pageof 130
Sort By:
Breast Cancer Research : BCR|March 31, 2017
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcomeMiriam Ragle Aure, Valeria Vitelli, Sandra Jernström, et al.
Archives of Physical Medicine and Rehabilitation|May 28, 2018
A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb SpasticityChris Boulias, Farooq Ismail, Chetan P Phadke, et al.
Nature Communications|April 10, 2019
Breast cancer quantitative proteome and proteogenomic landscapeHenrik J Johansson, Fabio Socciarelli, Nathaniel M Vacanti, et al.
Annals of Neurology|June 13, 2019
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementationViorica Chelban, Matthew P Wilson, Jodi Warman Chardon, et al.
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Cancer Cell|July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerKrishna M Vasudevan, David A Barbie, Michael A Davies, et al.
Cancer Discovery|June 13, 2015
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilitiesFerdinandos Skoulidis, Lauren A Byers, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Journal of Inherited Metabolic Disease|December 4, 2023
The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduriaSonam Gurung, Saketh Karamched, Dany Perocheau, et al.
Cell Reports|April 5, 2018
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome AtlasTheo A Knijnenburg, Linghua Wang, Michael T Zimmermann, et al.
Pageof 130

Showing results (1241-1250 of 1,298) with videos related to

Sort By:
Pageof 130
Breast Cancer Research : BCR|March 31, 2017
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcomeMiriam Ragle Aure, Valeria Vitelli, Sandra Jernström, et al.
Archives of Physical Medicine and Rehabilitation|May 28, 2018
A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb SpasticityChris Boulias, Farooq Ismail, Chetan P Phadke, et al.
Nature Communications|April 10, 2019
Breast cancer quantitative proteome and proteogenomic landscapeHenrik J Johansson, Fabio Socciarelli, Nathaniel M Vacanti, et al.
Annals of Neurology|June 13, 2019
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementationViorica Chelban, Matthew P Wilson, Jodi Warman Chardon, et al.
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Cancer Cell|July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerKrishna M Vasudevan, David A Barbie, Michael A Davies, et al.
Cancer Discovery|June 13, 2015
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilitiesFerdinandos Skoulidis, Lauren A Byers, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Journal of Inherited Metabolic Disease|December 4, 2023
The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduriaSonam Gurung, Saketh Karamched, Dany Perocheau, et al.
Cell Reports|April 5, 2018
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome AtlasTheo A Knijnenburg, Linghua Wang, Michael T Zimmermann, et al.
Pageof 130